vs
Side-by-side financial comparison of Ceribell, Inc. (CBLL) and GLADSTONE COMMERCIAL CORP (GOOD). Click either name above to swap in a different company.
GLADSTONE COMMERCIAL CORP is the larger business by last-quarter revenue ($43.5M vs $24.8M, roughly 1.8× Ceribell, Inc.). GLADSTONE COMMERCIAL CORP runs the higher net margin — 12.4% vs -54.6%, a 67.0% gap on every dollar of revenue.
Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.
Gladstone Commercial Corp is a publicly traded US real estate investment trust focused on acquiring, owning, and operating diversified industrial and commercial properties. It offers long-term net lease agreements to tenants across manufacturing, logistics, healthcare and professional services sectors, mainly serving small to mid-sized business clients.
CBLL vs GOOD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $24.8M | $43.5M |
| Net Profit | $-13.5M | $5.4M |
| Gross Margin | 87.3% | — |
| Operating Margin | -58.9% | — |
| Net Margin | -54.6% | 12.4% |
| Revenue YoY | — | 16.3% |
| Net Profit YoY | — | -25.1% |
| EPS (diluted) | $-0.35 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $24.8M | $43.5M | ||
| Q3 25 | $22.6M | $40.8M | ||
| Q2 25 | $21.2M | $39.5M | ||
| Q1 25 | $20.5M | $37.5M | ||
| Q4 24 | — | $37.4M | ||
| Q3 24 | $17.2M | $39.2M | ||
| Q2 24 | — | $37.1M | ||
| Q1 24 | — | $35.7M |
| Q4 25 | $-13.5M | $5.4M | ||
| Q3 25 | $-13.5M | $4.1M | ||
| Q2 25 | $-13.6M | $4.6M | ||
| Q1 25 | $-12.8M | $5.1M | ||
| Q4 24 | — | $7.2M | ||
| Q3 24 | $-10.4M | $11.7M | ||
| Q2 24 | — | $1.6M | ||
| Q1 24 | — | $3.5M |
| Q4 25 | 87.3% | — | ||
| Q3 25 | 88.3% | — | ||
| Q2 25 | 88.1% | — | ||
| Q1 25 | 87.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 87.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -58.9% | — | ||
| Q3 25 | -64.8% | — | ||
| Q2 25 | -70.5% | — | ||
| Q1 25 | -69.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -57.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -54.6% | 12.4% | ||
| Q3 25 | -59.6% | 10.1% | ||
| Q2 25 | -64.4% | 11.7% | ||
| Q1 25 | -62.4% | 13.7% | ||
| Q4 24 | — | 19.2% | ||
| Q3 24 | -60.6% | 29.8% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | — | 9.9% |
| Q4 25 | $-0.35 | $0.05 | ||
| Q3 25 | $-0.37 | $0.02 | ||
| Q2 25 | $-0.38 | $0.03 | ||
| Q1 25 | $-0.36 | $0.04 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | $-1.85 | $0.20 | ||
| Q2 24 | — | $-0.04 | ||
| Q1 24 | — | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $159.3M | $10.8M |
| Total DebtLower is stronger | — | $843.5M |
| Stockholders' EquityBook value | $155.3M | $171.8M |
| Total Assets | $195.8M | $1.2B |
| Debt / EquityLower = less leverage | — | 4.91× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $159.3M | $10.8M | ||
| Q3 25 | $168.5M | $18.4M | ||
| Q2 25 | $177.4M | $11.7M | ||
| Q1 25 | $182.7M | $10.4M | ||
| Q4 24 | — | $11.0M | ||
| Q3 24 | $14.1M | $10.5M | ||
| Q2 24 | — | $10.4M | ||
| Q1 24 | — | $10.5M |
| Q4 25 | — | $843.5M | ||
| Q3 25 | — | $843.3M | ||
| Q2 25 | — | $794.4M | ||
| Q1 25 | — | $740.7M | ||
| Q4 24 | — | $693.4M | ||
| Q3 24 | — | $692.6M | ||
| Q2 24 | — | $722.5M | ||
| Q1 24 | — | $719.4M |
| Q4 25 | $155.3M | $171.8M | ||
| Q3 25 | $164.1M | $184.8M | ||
| Q2 25 | $172.2M | $177.2M | ||
| Q1 25 | $180.9M | $183.2M | ||
| Q4 24 | — | $171.2M | ||
| Q3 24 | $-136.0M | $168.9M | ||
| Q2 24 | — | $145.7M | ||
| Q1 24 | — | $147.3M |
| Q4 25 | $195.8M | $1.2B | ||
| Q3 25 | $199.5M | $1.3B | ||
| Q2 25 | $207.7M | $1.2B | ||
| Q1 25 | $213.5M | $1.2B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $47.1M | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
| Q4 25 | — | 4.91× | ||
| Q3 25 | — | 4.56× | ||
| Q2 25 | — | 4.48× | ||
| Q1 25 | — | 4.04× | ||
| Q4 24 | — | 4.05× | ||
| Q3 24 | — | 4.10× | ||
| Q2 24 | — | 4.96× | ||
| Q1 24 | — | 4.88× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-10.8M | $88.2M |
| Free Cash FlowOCF − Capex | $-11.0M | — |
| FCF MarginFCF / Revenue | -44.2% | — |
| Capex IntensityCapex / Revenue | 0.7% | — |
| Cash ConversionOCF / Net Profit | — | 16.38× |
| TTM Free Cash FlowTrailing 4 quarters | $-41.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.8M | $88.2M | ||
| Q3 25 | $-11.1M | $18.9M | ||
| Q2 25 | $-7.5M | $35.8M | ||
| Q1 25 | $-11.4M | $17.7M | ||
| Q4 24 | — | $57.0M | ||
| Q3 24 | — | $5.5M | ||
| Q2 24 | — | $13.6M | ||
| Q1 24 | — | $15.0M |
| Q4 25 | $-11.0M | — | ||
| Q3 25 | $-11.5M | — | ||
| Q2 25 | $-7.6M | — | ||
| Q1 25 | $-11.6M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -44.2% | — | ||
| Q3 25 | -50.8% | — | ||
| Q2 25 | -35.9% | — | ||
| Q1 25 | -56.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 0.7% | — | ||
| Q3 25 | 1.6% | — | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 16.38× | ||
| Q3 25 | — | 4.57× | ||
| Q2 25 | — | 7.74× | ||
| Q1 25 | — | 3.44× | ||
| Q4 24 | — | 7.93× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | 8.44× | ||
| Q1 24 | — | 4.26× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBLL
| Products | $18.8M | 76% |
| Subscription | $6.0M | 24% |
GOOD
Segment breakdown not available.